Search
Estrella Immunopharma Inc
ESLAAdd to Watchlist
0.639USD
-0.090-12.35%
Close 10-30 16:00（ET）
27.80MMarket Cap
LossP/E TTM
ESLA Analyst Recommendation Trends
In the current month, ESLA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ESLA average Analyst price target in the last month is 12.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Financial Forecasting
Based on analysts' estimates, ESLA EPS is projected to reach -0.130 in FY2026Q3, following reported EPS of -0.054 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.11
-0.19
-0.18
-0.08
-0.07
Actual
-0.02
-0.05
-0.05
--
--
Surprise
+85.26%
+71.36%
+70.20%
--
--
FAQs
How have Estrella Immunopharma IncESLA's recent earnings per share performed?
The market expectation was USD -0.05, while Estrella Immunopharma IncESLA's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.13.